|
Cortex to Provide Shareholder Update and Host Conference Call on October 31, 2007.(Clinical report)
Business Wire
|
October 26, 2007
|
COPYRIGHT 2007 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group.
(Hide copyright information)
Copyright
|
Cortex's AMPAKINE[R] Technology Featured in November, 2007 National Geographic Magazine Focused on Memory
IRVINE, Calif. -- Cortex Pharmaceuticals, Inc. (AMEX: COR) will host a conference call on Wednesday, October 31, 2007 at 12:00 Noon EDT (9:00 AM PDT) to discuss the recently announced decision by the Division of Psychiatric Products (DPP) of the Food and Drug Administration to not permit the initiation of the proposed Phase IIb clinical study of CX717 in adult ADHD (attention deficit hyperactivity disorder), and its impact on the Company's development programs.
...
Find more facts and information related to the
article "Cortex to Provide Shareholder Update and Host ..."